Switching Mediterranean Consumers to Mediterranean Sustainable Healthy Dietary Patterns
Launched by FUNDACIÓ EURECAT · Sep 21, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The main outcome will be adherence to the MD assessed through MEDAS and KIDMED validated questionnaires in parents and children respectively. The effectiveness of the multi-component intervention will be evaluated by comparing the MEDAS and KIDMED scores between the control and intervention groups at baseline and at the end of the intervention.The secondary outcomes will include a set of anthropometrical, lifestyle, dietary and socio-economic indicators measured in all family members.
Standardized protocols will be used for the collection of data in the three countries. All data will be co...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Families from any socioeconomic status with at least one child less than 12 years and one adolescent older than or equal to 12 years (overall age range 3 - 17 years) and that live together.
- • Signed informed consent (parents will sign on their own behalf and of the child under 12 years of age and the adolescent. The adolescent must also sign themselves).
- • To have a mobile phone, tablet, or computer with internet access.
- Exclusion Criteria:
- • Having allergies or food intolerances to any of the snack ingredients: fruit, vegetables, legumes, cereals, seeds, nuts (only for children under 12 years).
- • Dislike any of the snacks (only for children under 12 years).
- • Mediterranean Diet Adherence Score (MEDAS) among 8-14 or KIDMED score among 8-12, which is a food pattern already highly concordant with the Mediterranean Diet.
- • Following a vegan diet any of the family members.
- • Following a prescribed long-term and strict diet for any reason, including diets for weight loss and diets for chronic metabolic or autoimmune disorders such as type 1 diabetes, celiac disease, inflammatory bowel disease or rheumatoid arthritis (any of the family members).
- • Participate in or have participated in a clinical trial or nutritional intervention study in the last 30 days prior to inclusion in the study.
- • No or limited access to the Internet.
- • Being unable to follow the study guidelines.
About Fundació Eurecat
Fundació Eurecat is a leading technology and knowledge transfer center based in Catalonia, Spain, dedicated to fostering innovation and enhancing competitiveness across various sectors. As a clinical trial sponsor, Eurecat leverages its multidisciplinary expertise in research and development to support the advancement of medical technologies and therapeutic solutions. Committed to promoting collaborative projects, Eurecat engages with academic institutions, industry partners, and healthcare organizations to drive the translation of scientific discoveries into effective clinical applications, ensuring the highest standards of quality and compliance throughout the trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reus, Tarragona, Spain
Patients applied
Trial Officials
Antoni Caimari Palou, PhD
Principal Investigator
Fundació Eurecat
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported